Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Heike Wulff

Showing results (61-70 of 222) with videos related to

Pageof 23
Sort By:
Glia|July 26, 2018
The voltage-gated potassium channel Kv1.3 is required for microglial pro-inflammatory activation in vivoJacopo Di Lucente, Hai M Nguyen, Heike Wulff, et al.
Assay and Drug Development Technologies|December 20, 2013
Development of a QPatch automated electrophysiology assay for identifying KCa3.1 inhibitors and activatorsDavid Paul Jenkins, Weifeng Yu, Brandon M Brown, et al.
Metabolism: Clinical and Experimental|August 20, 2024
Targeting endothelial K<sub>Ca</sub> channels in vivo restores arterial and endothelial function in type 2 diabetic ratsRamesh C Mishra, Darrell D Belke, Latika Singh, et al.
Frontiers in Pharmacology|May 14, 2023
Immunocytoprotection after reperfusion with Kv1.3 inhibitors has an extended treatment window for ischemic strokeRuth D Lee, Yi-Je Chen, Latika Singh, et al.
Pharmacological Reviews|October 15, 2025
Recent advances in the pharmacology of voltage-gated ion channelsDiego Lopez-Mateos, Brandon John Harris, Adriana Hernández-González, et al.
Pediatric Diabetes|May 14, 2016
Treatment with the KCa3.1 inhibitor TRAM-34 during diabetic ketoacidosis reduces inflammatory changes in the brainNicole Glaser, Christopher Little, Weei Lo, et al.
European Journal of Human Genetics : EJHG|March 16, 2002
Characterisation of the human voltage-gated potassium channel gene, KCNA7, a candidate gene for inherited cardiac disorders, and its exclusion as cause of progressive familial heart block I (PFHBI)Soraya Bardien-Kruger, Heike Wulff, Zainu Arieff, et al.
Acta Pharmaceutica (Zagreb, Croatia)|July 3, 2025
Exploration of the chemical space of benzamide-based voltage-gated potassium channel K<sub>v</sub>1.3 inhibitorsMarzia Fois, Špela Pelcar, Joshua A Nasburg, et al.
BMJ Open Diabetes Research & Care|May 18, 2022
Effects of TRAM-34 and minocycline on neuroinflammation caused by diabetic ketoacidosis in a rat modelNicole Glaser, Steven Chu, Justin Weiner, et al.
Journal of Clinical Toxicology|March 4, 2017
Inhibition of soluble epoxide hydrolase as a novel approach to high dose diazepam induced hypotensionArzu Ulu, Bora Inceoglu, Jun Yang, et al.
Pageof 23

Showing results (61-70 of 222) with videos related to

Sort By:
Pageof 23
Glia|July 26, 2018
The voltage-gated potassium channel Kv1.3 is required for microglial pro-inflammatory activation in vivoJacopo Di Lucente, Hai M Nguyen, Heike Wulff, et al.
Assay and Drug Development Technologies|December 20, 2013
Development of a QPatch automated electrophysiology assay for identifying KCa3.1 inhibitors and activatorsDavid Paul Jenkins, Weifeng Yu, Brandon M Brown, et al.
Metabolism: Clinical and Experimental|August 20, 2024
Targeting endothelial K<sub>Ca</sub> channels in vivo restores arterial and endothelial function in type 2 diabetic ratsRamesh C Mishra, Darrell D Belke, Latika Singh, et al.
Frontiers in Pharmacology|May 14, 2023
Immunocytoprotection after reperfusion with Kv1.3 inhibitors has an extended treatment window for ischemic strokeRuth D Lee, Yi-Je Chen, Latika Singh, et al.
Pharmacological Reviews|October 15, 2025
Recent advances in the pharmacology of voltage-gated ion channelsDiego Lopez-Mateos, Brandon John Harris, Adriana Hernández-González, et al.
Pediatric Diabetes|May 14, 2016
Treatment with the KCa3.1 inhibitor TRAM-34 during diabetic ketoacidosis reduces inflammatory changes in the brainNicole Glaser, Christopher Little, Weei Lo, et al.
European Journal of Human Genetics : EJHG|March 16, 2002
Characterisation of the human voltage-gated potassium channel gene, KCNA7, a candidate gene for inherited cardiac disorders, and its exclusion as cause of progressive familial heart block I (PFHBI)Soraya Bardien-Kruger, Heike Wulff, Zainu Arieff, et al.
Acta Pharmaceutica (Zagreb, Croatia)|July 3, 2025
Exploration of the chemical space of benzamide-based voltage-gated potassium channel K<sub>v</sub>1.3 inhibitorsMarzia Fois, Špela Pelcar, Joshua A Nasburg, et al.
BMJ Open Diabetes Research & Care|May 18, 2022
Effects of TRAM-34 and minocycline on neuroinflammation caused by diabetic ketoacidosis in a rat modelNicole Glaser, Steven Chu, Justin Weiner, et al.
Journal of Clinical Toxicology|March 4, 2017
Inhibition of soluble epoxide hydrolase as a novel approach to high dose diazepam induced hypotensionArzu Ulu, Bora Inceoglu, Jun Yang, et al.
Pageof 23